StoneX and Expana Partner to Introduce OTC Dairy Derivatives

StoneX and Expana will launch OTC dairy derivatives on October 7, 2025, benchmarked against Expana’s EU dairy indices. Initially focusing on fat-filled milk powder and high-protein whey, the collaboration aims to provide granular hedging tools. Integration into StoneX Plus offers seamless access to pricing data, enhancing price discovery and liquidity. The derivatives address the rising need for risk management amid dairy sector volatility. Expansion to other dairy products is planned for a comprehensive risk management ecosystem.

“`html

StoneX (NASDAQ: SNEX) and Expana are set to disrupt the dairy derivatives market with the launch of a new suite of over-the-counter (OTC) contracts, slated for October 7, 2025. These derivatives will be benchmarked against Expana’s EU dairy indices, which adhere to IOSCO principles. The collaboration initially focuses on fat-filled milk powder and high-protein whey, signaling a strategic move to provide more granular and reliable hedging tools for these key commodities. Future expansion to other dairy products is planned, aiming to create a comprehensive risk management ecosystem for industry participants.

Integrating Expana’s benchmarks directly into the StoneX Plus trading platform will give users seamless access to crucial pricing data, a development poised to enhance price discovery, increase market liquidity, and offer more precise hedging instruments for global dairy market players. Market analysts suggest this move addresses the growing need for sophisticated risk management solutions in the face of increasing volatility in the dairy sector, driven by factors such as changing consumer preferences and supply chain disruptions.

Positive

  • Launch of OTC dairy derivatives referencing IOSCO-assured benchmarks enhances credibility
  • Initial contracts cover fat-filled milk powder and high-protein whey, targeting key market segments.
  • Direct integration into StoneX Plus trading workflow improves accessibility
  • Aimed to improve price transparency and liquidity for dairy markets, benefiting all participants

Negative

  • No disclosed financial terms, which makes quantitative market impact assessment difficult. Future growth expectations are unclear
  • Coverage initially limited to two dairy products could limit initial widespread adoption. It will take some time to scale up new products

`
summaryContainer.insertAdjacentHTML(‘beforeend’, translationDropdownHTML);

document.querySelectorAll(‘.dropdown-item.item-translation’).forEach(item => {
item.addEventListener(‘click’, function(event) {
event.preventDefault();
const lang = this.getAttribute(‘data-lang’);
switchLanguage(lang);
});
});
}
}

fetchTranslations();
}

function switchLanguage(lang) {
// Hide all summaries
document.querySelectorAll(‘.rhea-summary, #summary’).forEach(element => {
element.classList.add(‘d-none’);
});

// Show the selected language summary
const summaryElement = document.getElementById(‘summary-‘ + lang) || document.getElementById(‘summary’);
if (summaryElement) {
summaryElement.classList.remove(‘d-none’);
}

// Save the selected language to localStorage
localStorage.setItem(‘preferredLanguage’, lang);
}

10/07/2025 – 06:27 AM

HAMBURG, Germany—StoneX Financial Europe GmbH (SFEG), a subsidiary of StoneX Group Inc. (NASDAQ: SNEX), is partnering with Expana to introduce a new suite of over-the-counter (OTC) dairy derivatives benchmarked against Expana’s IOSCO-assured EU dairy indices. The move aims to expand risk management tools available to the global dairy industry and bolster price transparency, the companies announced Tuesday.

The initial contracts will cover fat-filled milk powder and high-protein whey. Plans are in place to extend coverage to additional dairy products over time, responding to the evolving needs of the market. StoneX Plus users will gain direct access to Expana’s benchmarks within their trading workflows, which company executives say will enable them to make more informed hedging and risk management decisions.

“This collaboration with StoneX marks a significant milestone for the dairy industry,” stated Spencer Wicks, CEO of Expana. “By combining Expana’s independent IOSCO-assured benchmarks with StoneX’s expertise in OTC and futures dairy markets, we are developing tools to enhance effective and transparent dairy risk management over the long term.”

Liam Fenton, Global Head of Dairy & Food Group at StoneX, noted, “Our clients in the global dairy sector are increasingly seeking innovative methods to manage risk and navigate market volatility. Working with Expana provides them access to reliable, independent benchmarks that improve liquidity, support transparent pricing, and ultimately strengthen risk management across the industry.”

StoneX: A Deep Dive into Dairy Derivatives

The partnership addresses a growing need for sophisticated risk management tools in the global dairy market. Dairy producers and processors face increasing price volatility stemming from factors like shifts in consumer preferences (e.g., the rising popularity of plant-based alternatives), supply chain disruptions exacerbated by geopolitical events, and climate-related impacts on milk production.

By offering derivatives based on IOSCO-compliant benchmarks, StoneX / Expana will provide market participants with a degree of standardization and reliability previously lacking in the OTC dairy derivatives space. This has the potential to unlock new investment and trading opportunities, attracting institutional investors who often require a higher level of regulatory assurance.

The Technology Angle

Integrating Expana’s data within the StoneX Plus platform is a strategic technology enhancement. This provides sophisticated analytics and modeling tools will allow users to quickly assess market dynamics, evaluate risk exposures, and execute hedging strategies – a critical advantage in a fast-moving global market.

The introduction of these new OTC dairy derivatives marks a key moment in the evolution of risk management in the global dairy industry. By combining the strength of StoneX’s market position with Expana’s benchmarking expertise, dairy market participants now have new opportunities to manage their risk exposures in a more transparent and efficient way.

About StoneX

A Fortune 50 company headquartered in New York City and listed on the Nasdaq Global Select Market (NASDAQ: SNEX), StoneX Group Inc. and its more than 4,700 employees serve over 54,000 commercial, institutional, and payments clients, as well as more than 400,000 retail accounts, across more than 80 offices on six continents. Further information is available at www.stonex.com.

About Expana

Expana is the world’s leading agrifood-focused price reporting agency and global information provider, enabling organizations to make smarter strategic decisions. In markets defined by volatility, opacity, and risk, Expana equips organizations with the foresight to know when to buy or sell, how much, where to source, what to reformulate, and how to price. By uniting frequently updated pricing data, predictive forecasts, cost modeling, and expert analysis, Expana transforms market data into negotiation power and boardroom-ready intelligence. For more information, visit https://www.expanamarkets.com/product/expana-platform/.

SNEX-G

StoneX and Expana Partner to Introduce OTC Dairy Derivatives
StoneX and Expana Partner to Introduce OTC Dairy Derivatives

For press enquiries please contact [email protected]

FAQ

What did StoneX and Expana announce on October 7, 2025 regarding SNEX?

They announced a collaboration to launch OTC dairy derivatives referencing Expana’s IOSCO-assured EU dairy benchmarks.

Which dairy products will the new SNEX-referenced OTC contracts cover first?

The first contracts will cover fat-filled milk powder and high-protein whey.

How will StoneX Plus users benefit from the Expana collaboration?

StoneX Plus users will gain direct access to Expana benchmarks within their trading workflow to support hedging and risk management.

Does the announcement specify financial terms or launch dates for SNEX derivatives?

No; the announcement does not disclose financial terms or specific launch dates.

What is the investor implication of using IOSCO-assured benchmarks with SNEX products?

Using IOSCO-assured benchmarks is intended to enhance benchmark independence and price transparency for market participants.

Stonex Group Inc

NASDAQ:SNEX

SNEX Stock Data



5.27B


46.99M


9.97%


78.7%


3.09%


Capital Markets


Security & Commodity Brokers, Dealers, Exchanges & Services


United States


NEW YORK

“`

Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/10500.html

Like (0)
Previous 18 hours ago
Next 2 hours ago

Related News